跳至主要内容
临床试验/NCT07751159
NCT07751159招募中2 期

Balancing Radiation Intensification and Quality of Life in Higher-Risk Prostate Cancer (The BALANCE-RT Trial)

Memorial Sloan Kettering Cancer Center7 个研究点 分布在 1 个国家目标入组 126 人开始时间: 2026年7月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
126
试验地点
7
主要终点
Change in International Prostate Symptom Score / IPSS at 3 months

研究概览

简要总结

The purpose of the study is to explore the best ways of giving radiation therapy to balance cancer control and treatment side effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Non-metastatic prostate cancer.
  • Classified as unfavorable intermediate-, high-, or very high-risk prostate cancer according to NCCN risk stratification guidelines. (Note: cT3a or T3b by MRI or PSMA PET allowed)
  • Considered by the treating radiation oncologist as a suitable candidate for both HDR brachytherapy boost and SBRT

排除标准

  • 未提供

研究组 & 干预措施

Arm A: HDR Brachytherapy Boost + SBRT

Active Comparator

Standard of Care Brachytherapy/Radiation and SBRT

干预措施: SBRT (Radiation)

Arm B: SBRT Alone

Experimental

SBRT alone

干预措施: SBRT (Radiation)

Arm A: HDR Brachytherapy Boost + SBRT

Active Comparator

Standard of Care Brachytherapy/Radiation and SBRT

干预措施: Standard of Care HDR Brachytherapy (Radiation)

结局指标

主要结局

Change in International Prostate Symptom Score / IPSS at 3 months

时间窗: 3 months

Change in International Prostate Symptom Score / IPSS to measure if SBRT alone results in less acute patient reported urinary symptoms measured by IPSS at 3 months than HDR brachytherapy boost combined with SBRT

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

Radiation Therapy Approaches for People With... | 临床试验